The Oncologist, Vol. 8, Suppl 1, 1014,
February 2003
© 2003 AlphaMed Press
Treating Fatigue in Cancer Patients
Ann Berger
Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland, USA
Correspondence:
Ann Berger, R.N., M.S.N., M.D., National Institutes of Health, Clinical Center, Building 10, Room 2N236, 10 Center Drive, Bethesda, Maryland 20892, USA. Telephone: 301-594-9766; Fax: 301-594-9807; e-mail: aberger{at}cc.nih.gov
Possible causes of cancer-related fatigue include depression, pain, sleep problems, anemia, deconditioning, metabolic abnormalities, infection, dietary problems, hypoxia, and side effects of medication. Although treatments are available for each of these conditions, there are no generally accepted treatments available for the whole fatigue syndrome. There are also very few studies on the treatment of cancer-related fatigueonly 10 randomized controlled trials. Health care providers have begun to understand that, just as the treatment of pain requires attention to imbalances in mind, body, and spirit, the treatment of fatigue will require such an approach.
Key Words. Fatigue • Neoplasms • Depression • Anemia • Sleep disorders
This article has been cited by other articles:

|
 |

|
 |
 
J. K. Carroll, S. Kohli, K. M. Mustian, J. A. Roscoe, and G. R. Morrow
Pharmacologic Treatment of Cancer-Related Fatigue
Oncologist,
May 1, 2007;
12(suppl_1):
43 - 51.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Mustian, G. R. Morrow, J. K. Carroll, C. D. Figueroa-Moseley, P. Jean-Pierre, and G. C. Williams
Integrative Nonpharmacologic Behavioral Interventions for the Management of Cancer-Related Fatigue
Oncologist,
May 1, 2007;
12(suppl_1):
52 - 67.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sood, D. L. Barton, B. A. Bauer, and C. L. Loprinzi
A Critical Review of Complementary Therapies for Cancer-Related Fatigue
Integr Cancer Ther,
March 1, 2007;
6(1):
8 - 13.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Hartvig, J. Aulin, S. Wallenberg, and G. Wagenius
Physical exercise for cytotoxic drug-induced fatigue
Journal of Oncology Pharmacy Practice,
December 1, 2006;
12(4):
183 - 191.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Wood, L. M. Nail, N. A. Perrin, C. R. Elsea, A. Fischer, and B. J. Druker
The Cancer Chemotherapy Drug Etoposide (VP-16) Induces Proinflammatory Cytokine Production and Sickness Behavior-like Symptoms in a Mouse Model of Cancer Chemotherapy-Related Symptoms.
Biol Res Nurs,
October 1, 2006;
8(2):
157 - 169.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Daly
Introduction: All Ireland Fatigue Coalition
Oncologist,
February 1, 2003;
8(90001):
1 - 2.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by AlphaMed Press.
|
|